We believe the shipment of these QS explosives detection devices is an important milestone in our product commercialization and distribution strategy.
The military agencies that have accepted delivery of the QS should play an important role in determining the suitability of our explosives detection device for procurement by other military agencies, as well as gaining actual field experience in the use and performance of the QS.
Although we have not been apprised of the evaluation schedules or field deployment logistics for these units, we will offer our assistance to these agencies to facilitate the evaluation process and ensure satisfactory performance.
With the completion of these important military shipments, the Company continues its ongoing discussions with other U.S. government agencies to explore the potential for further exploitation of the Company's explosives detection technology and products as part of the ongoing task of increasing the security for our nation against terrorist attacks.
The Company is also in negotiations with several international distributor candidates who, once selected, will become important in our strategy to extend our sales and marketing reach to the international marketplace.
With the previous announcement of the selection of Jabil Circuit, Inc. (NYSE: "JBL"), the Company believes it possesses the necessary resources to meet potential orders that may be procured from U.S. government and military agencies, and other customers in the private and public sectors, both domestic and international.
The QS is the Company's trace explosives detection device using the Company's patented, proprietary QS Ion Mobility Spectrometry technology, which electronically detects minute quantities of explosive vapor molecules in the air.
These units may be used to determine the presence of, or confirm the absence of, common explosives in personal equipment, packages, postal mail and cargo that may be conveyed by persons, vehicles, airplanes, and watercraft.
Dr. Anthony J. Armini, PhD., CEO of Implant Sciences, commented, "With the shipment of the fifteen units ordered by these two military agencies, Implant Sciences has officially entered the security business. We are no longer another company attempting to enter the Homeland Defense arena with a product awaiting years of development to prove that a commercial product might result."
"Our QS has gone through several years of development to prove that a technological vision could be transformed to a viable commercial product."
"We have undergone rigorous testing along the way in our efforts to meet the standards and requirements presented us by various government and military agencies which may be interested in the possibility of deploying our technology."
"While transforming the QS from a crude prototype to a sleek, yet effective device for the detection of trace explosives, we have also executed on the other strategic initiatives necessary to produce and distribute what we believe will be the first of many successful products in the security industry."
Dr. Armini further commented, "However, in as much as we are proud of our current accomplishment of introducing our new QS product, which we believe to be technologically superior and more effective in the effort to detect trace explosives, we also know we cannot standstill while the marketplace demands better technology and improvements in the way we screen passengers, articles, and cargo for the potential of explosives and toxic materials."
"To that end, we will continue to seek outside funding, through government and corporate sources, and invest available internally generated capital in our development of other important products, such as devices to screen passengers entering security checkpoints and automate the way we screen baggage and cargo for trace explosives."